Related Experiment Video
Updated: Jun 4, 2026

Bacterial Expression and Purification of Human Matrix Metalloproteinase-3 using Affinity Chromatography
Published on: March 30, 2022
[Matrix metalloproteinases and atherosclerosis]
Piotr Fic1, Izabela Zakrocka, Jacek Kurzepa
1Oddział Kardiologii z Pododdziałem Kardiologii Inwazyjnej, Specjalistyczny Szpital Wojewódzki im. Kardynała Stefana Wyszyńskiego w Lublinie.
Abstract:
Matrix metalloproteinases (MMPs), a family of proteolytic enzymes that degrade extracellular matrix (ECM), seem to have an important role in pathogenesis of atherosclerosis. Released by inflammatory cells and smooth muscle cells, MMPs regulate the vascular remodeling process. The expression and activity of MMPs is regulated at the level of transcription by a variety of cytokines, proenzyme activation by several cellular and serum proteases, as well as by endogenous and exogenous inhibitors. Overproduction of MMPs could promote arteriosclerosis, leading to atherosclerotic plaque formation, and plaque rupture, resulting in clinical consequences such as myocardial infarction, or critical limb ischemia. Increased plasma levels of some MMPs are now regarded as potential biomarkers of atherosclerosis and cardiovascular risk. The potential significance of MMP inhibitors in atherosclerosis therapy is discussed.
Insights
Matrix metalloproteinases (MMPs) play a key role in atherosclerosis development and plaque rupture. Targeting MMPs may offer new therapeutic strategies for cardiovascular disease.
Area of Science:
- Biochemistry
- Cardiovascular Biology
- Molecular Medicine
Context:
- Atherosclerosis involves complex molecular processes, including extracellular matrix (ECM) degradation.
- Matrix metalloproteinases (MMPs), ECM-degrading enzymes, are implicated in vascular remodeling.
- Inflammatory cells and smooth muscle cells release MMPs, influencing atherosclerotic plaque development.
Purpose:
- To explore the role of MMPs in the pathogenesis of atherosclerosis.
- To discuss the regulation of MMP expression and activity.
- To evaluate the potential of MMP inhibitors as a therapeutic strategy for atherosclerosis.
Summary:
- MMPs are proteolytic enzymes crucial for ECM turnover and vascular remodeling.
- Dysregulated MMP activity, often due to overproduction, contributes to atherosclerotic plaque formation and rupture.
- Elevated MMP levels in plasma are potential biomarkers for cardiovascular risk.
- MMP inhibitors are being investigated for their therapeutic potential in treating atherosclerosis.
Impact:
- Understanding MMPs' role enhances our knowledge of atherosclerosis pathogenesis.
- Increased plasma MMP levels may serve as early indicators of cardiovascular risk.
- MMP inhibitors represent a promising avenue for novel atherosclerosis therapies.
- This research could lead to improved clinical outcomes for patients with cardiovascular disease.
Related Concept Videos
Role of Matrix Metalloproteases in Degradation of ECM
A...
Atherosclerosis I: Introduction
Coronary Artery Disease II: Pathophysiology
Atherosclerosis III: Management
Coronary Artery Disease I: Introduction
The Extracellular Matrix

